Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Liabilities from Discontinued Operations (2019 - 2020)

Historic Liabilities from Discontinued Operations for Cumberland Pharmaceuticals (CPIX) over the last 2 years, with Q1 2020 value amounting to $1.2 million.

  • Cumberland Pharmaceuticals' Liabilities from Discontinued Operations changed N/A to $1.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2019, which is N/A changed from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Liabilities from Discontinued Operations of $1.2 million as of Q1 2020.
  • In the past 5 years, Cumberland Pharmaceuticals' Liabilities from Discontinued Operations ranged from a high of $2.2 million in Q4 2019 and a low of $1.2 million during Q1 2020